Michael Sherman sherm at symdyn.com
Tue Feb 8 01:49:28 EST 2000

deborah konietzko <dktaraworks at bigplanet.com> wrote:
> Do you have a reference for the biochemistry of it?  If it has been
> shown to be safe, I'm willing to be that it is, or is in the process of,
> being made available somewhere for those health entrepreneurs or
> health-freedom folks who are willing to bet on it's effectiveness in
> humans, unwilling to wait for the FDA's official approval stamp.
> Dr. Deb

I don't have a reference, but the ALT711 (and many related compounds)
is patented by Alteon, which I believe requires full disclosure.  The
patent numbers would be available from Alteon and the patents themselves
are probably online and freely viewable.

Please post if you find out anything interesting.


P.S. I'm not sure this is an urgent matter for most of us.  If I
understand the purported mechanism of action, a two-week course of ALT711
can unwind many years of glycosylation.  If so I'm content for
now to wait for wide availability.  Could be a different story for
someone with advanced diabetic complications, though.

More information about the Ageing mailing list

Send comments to us at biosci-help [At] net.bio.net